Drug Companies Update Dec 2007
Mergers, acquisitions & Joint Ventures
- Neuren has acquired Hamilton Pharmaceuticals.
- Recordati has acquired Orphan Europe, a pharmaceutical company developing and distributing orphan drugs for the treatment of rare diseases.
- Somanta has been acquired by emerging biopharmaceutical company, Access Pharmaceuticals.
- Drug delivery outfit Orexo has acquired inflammatory-disease focused Biolipox in an all-Swedish affair.
- Biotechnology company Biomira has changed its name to Oncothyreon.
New Companies
- Clarus Therapeutics is dedicated to the development and commercialization of androgen-based therapeutics.
- Inspiration Therapeutics is engaged in the development of innovative blood recombinant blood coagulation factor products to fundamentally change the treatment of hemophilia.
- MaxThera is a biopharmaceutical company focused on the development of new therapeutics for bacterial infections.
- AIM Therapeutics focuses on the development of products for the treatment of immune and inflammatory disorders.
- Japan-based CellSeed is focused on novel surface and cell culture products for regenerative medicine.
- CNSBio is a clinical-stage biotechnology company commercializing novel combination therapies for the treatment of pain and other diseases of the nervous system.
- Privately-owned IGAN Biosciences IGAN Biosciences is working to create an effective treatment for IgA nephropathy.
- PLx Pharma is developing next-generation NSAIDs that are safe on the gut.
- Clarus Therapeutics is developing an oral delivery technology, focusing initially on producing a formulation of testosterone.
- UK-based eTherapeutics is a systems biology drug discovery company.
- Excaliard is a biotechnology company developing antisense therapeutics for the treatment of scarring and other fibrotic disorders.
- MaxThera is a biopharmaceutical company that discovers and develops antibacterials, particularly against resistant strains.
- Ophthotech is developing therapies for the treatment of age-related macular degeneration.
- Osmotica specialises in drug delivery technology and neurology-based therapeutics.
- Quantum Genomics is a biotechnology compnay working in the fields of recombinant proteins, antibodies and advanced chemical compounds.
- Virobay is investigating protease and polymerase inhibitors for the treatment of hepatitis-C virus infection.
- Vitreo Retinal Technologies is focused on the development of therapeutics and diagnostics for serious ocular diseases.
